Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve audited financial results ....
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has informed stock exchanges that its Board of Directors will meet on Tuesday, May 20, 2025. The main items on the agenda are approval of the audited financial results for the quarter and full year ended March 31, 2025, and recommendation of a final dividend for FY25. The company has also notified that the insider trading window will remain closed until May 22, 2025 and reopen on May 23, 2025. No financial figures or dividend amount have been disclosed in this advance notice.
This is a routine pre-results intimation, not an earnings update. Shareholders should watch for the actual results and dividend announcement on or after May 20, 2025, which could move the stock based on performance and payout.